NEW YORK, May 15, 2023 /PRNewswire/ — Attention Relmada Therapeutics, Inc. (“Relmada” or the “Company”) (NYSE: RLMD) shareholders: The Law Offices of Vincent Wong announce that an investigation has commenced into Relmada and certain of its officers and directors regarding potential…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.